(1H-Indol-4-yl)methanamine

Catalog No.: 
ACCOZP420
CAS No.: 
3468-18-6
Molecular Formula: 
C9H10N2
Molecular Weight: 
146.19
(1H-Indol-4-yl)methanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$129.00In stockInquiry
25g95%$590.00In stockInquiry
100g95%$2218.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1H-Indol-4-yl)methanamine
IUPAC Name(1H-indol-4-yl)methanamine
MDL No.MFCD04973297
Molecular FormulaC9H10N2
Molecular Weight146.19
SMILESNCC1=CC=CC2=C1C=CN2
InChI KeyFFBWKPKOXRMLNP-UHFFFAOYSA-N
Synonym4-(Aminomethyl)indole, 95% | AS-39487 | J-019710 | 4-(Aminomethyl)indole | 4-(aminomethyl)-indole | SY027224 | (1H-Indol-4-ymetyl)amine | 1-(1H-indol-4-yl)methanamine | c-(1h-indol-4-yl)methylamine | C-(1H-Indol-4-yl)-methylamine | EN300-333061 | 1h-indol
CAS No.3468-18-6
PubChem CID280302

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACCOZP420 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCQXK947 route compound structure diagram
    ACCQXK94716136-52-0In Stock
  2. Then
  3. ACCOZP420 route product structure diagram
    ACCOZP4203468-18-6In Stock
Inquiry

2. ACCOZP420 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  2. Plus
  3. ACAYOD052 route compound structure diagram
    ACAYOD0521074-86-8In Stock
  4. Then
  5. ACCOZP420 route product structure diagram
    ACCOZP4203468-18-6In Stock
Inquiry

3. ACCOZP420 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCOZP420 route product structure diagram
    ACCOZP4203468-18-6In Stock
Inquiry

Comments (0)